Purchases and Sales Made in Q2 2024 in Protalix Bio Therapeutics, Inc. (PLX)
This table provides information about the institutional ownership of Protalix Bio Therapeutics, Inc. (PLX) during Q2 2024. The information is specifically focused on institutions that hold shares of Protalix BioTherapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-85.9K- 49.65% |
$94.5K - $113K
|
87.1K
$220K
|
|
|
Oct 17, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-85.9K- 49.65% |
$94.5K - $113K
|
87.1K
$220K
|
|
|
Aug 15, 2024
Q2 2024
|
Gsa Capital Partners LLP
London, X0 |
SELL
|
- |
-92.3K- 18.71% |
$102K - $122K
|
401K
$1.01M
|
|
|
Aug 13, 2024
Q2 2024
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-2.98M- 89.94% |
$3.28M - $3.93M
|
333K
$840K
|